Why invest in early psychosis intervention services?

Early Intervention in Psychiatry

Volumn 3, Issue 4, 2009, Pages 237-238

  Mihalopoulos, Cathrine ^a  

^a DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

COMMUNITY CARE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DEPRESSION; EARLY INTERVENTION; EDITORIAL; HEALTH CARE POLICY; MEDICAL DECISION MAKING; MENTAL HEALTH; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PRIORITY JOURNAL; PSYCHOSIS; SCHIZOPHRENIA; SOCIOECONOMICS;

DECISION SUPPORT TECHNIQUES; EARLY MEDICAL INTERVENTION; HEALTH CARE COSTS; HUMANS; PSYCHOTIC DISORDERS;

EID: 70849087882     PISSN: 17517885     EISSN: 17517893     Source Type: Journal    
DOI: 10.1111/j.1751-7893.2009.00149.x     Document Type: Editorial

References (11)

1. Carter R, Vos T, Moodie M, Haby M, Magnus A, Mihalopoulos C. Priority setting in health: origins, description and application of the Australian assessing cost effectiveness (ACE) initiative. Expert Rev Pharmacoecon Outcomes Res 2008, 8:593-617.
2. McCrone P, Knapp M, Dhanasiri S. Economic impact of services for first-episode psychosis: a decision model approach. Early Interv Psychiatry 2009, 3:266-273.
3. Mihalopoulos C, McGorry PD, Carter RC. Is phase-specific, community-oriented treatment of early psychosis an economically viable method of improving outcome?. Acta Psychiatr Scand 1999, 100:47-55.
4. Mihalopoulos C, Harris M, Henry L, Harrigan S, McGorry PD. Is early intervention in psychosis cost-effective over the long term?. Schizophr Bull 2009, 35:909-18.
5. Cullberg J, Mattsson M, Levander S, Holmqvist R, Tomsmark L, Elingfors C. Treatment costs and clinical outcome for first episode schizophrenia patients: a 3-year follow-up of the Swedish 'Parachute Project' and Two Comparison Groups. Acta Psychiatr Scand 2006, 114:274-81.
6. Bertelsen M, Jeppesen P, Petersen L, Thorup A, Ohlenschlaeger J, le Quach P. Five-year follow-up of a randomized multicenter trial of intensive early intervention vs standard treatment for patients with a first episode of psychotic illness. Arch Gen Psychiatry 2008, 65:762-71.
7. Smit F, Willemse G, Koopmanschap M, Onrust S, Cuijpers P, Beekman A. Cost-effectiveness of preventing depression in primary care patients: randomised trial. Br J Psychiatry 2006, 188:330-6.
8. Andrews G, Issakidis C, Sanderson K, Corry J, Lapsley H. Utilising survey data to inform public policy: comparison of the cost-effectiveness of treatment of ten mental disorders. Br J Psychiatry 2004, 184:526-33.
9. Vos T, Haby MM, Magnus A, Mihalopoulos C, Andrews G, Carter R. Assessing cost-effectiveness in mental health: helping policy-makers prioritize and plan health services. Aust N Z J Psychiatry 2005, 39:701-12.
10. Manschreck TC, Boshes RA. The CATIE schizophrenia trial: results, impact, controversy. Harv Rev Psychiatry 2007, 15:245-58.
11. Knapp M, Chisholm D, Leese M, Amaddeo F, Tansella M, Schene A. Comparing patterns and costs of schizophrenia care in five European countries: the EPSILON study. Acta Psychiatr Scand 2002, 105:42-54.